Our Passion, Your Health.

2015

2 November 2015

Fidia Presents Hymovis®, a New Generation Hyaluronan, at the ACR Annual Meeting in San Francisco

Hymovis®, which was recently approved by the FDA in the U.S., is a highly viscoelastic hydrogel (HYADD®4) engineered using a proprietary process that increases lubrication and shock absorption properties
PARSIPPANY, N.J., Nov. 2, 2015 – Fidia Farmaceutici, a world leader in the research, development and manufacturing of hyaluronic acid (HA)-based products, and its wholly owned subsidiary,

 

Our Four Leading Principles:

Innovation

Quality

Internationalization

Competitiveness